Literature DB >> 11707421

Topoisomerase II can unlink replicating DNA by precatenane removal.

I Lucas1, T Germe, M Chevrier-Miller, O Hyrien.   

Abstract

We have analysed the role of topoisomerase II (topo II) in plasmid DNA replication in Xenopus egg extracts, using specific inhibitors and two-dimensional gel electrophoresis of replication products. Topo II is dispensable for nuclear assembly and complete replication of plasmid DNA but is required for plasmid unlinking. Extensive unlinking can occur in the absence of mitosis. Replication intermediates generated in the absence of topo II activity have an increased positive superhelical stress (+DeltaLk), suggesting a deficiency in precatenane removal. The geometry of replication intermediates cut by poisoning topo II with etoposide and purified by virtue of their covalent attachment to topo II subunits demonstrates that topo II acts behind the forks at all stages of elongation. These results provide direct evidence for unlinking replicating DNA by precatenane removal and reveal a division of labour between topo I and topo II in this eukaryotic system. We discuss the role of chromatin structure in driving DNA unlinking during S phase.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11707421      PMCID: PMC125741          DOI: 10.1093/emboj/20.22.6509

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  57 in total

1.  Formation of knots in partially replicated DNA molecules.

Authors:  J M Sogo; A Stasiak; M L Martínez-Robles; D B Krimer; P Hernández; J B Schvartzman
Journal:  J Mol Biol       Date:  1999-02-26       Impact factor: 5.469

2.  The localization of replication origins on ARS plasmids in S. cerevisiae.

Authors:  B J Brewer; W L Fangman
Journal:  Cell       Date:  1987-11-06       Impact factor: 41.582

3.  The structure of supercoiled intermediates in DNA replication.

Authors:  B J Peter; C Ullsperger; H Hiasa; K J Marians; N R Cozzarelli
Journal:  Cell       Date:  1998-09-18       Impact factor: 41.582

4.  Nuclear reconstitution in vitro: stages of assembly around protein-free DNA.

Authors:  J Newport
Journal:  Cell       Date:  1987-01-30       Impact factor: 41.582

5.  Topoisomerase inhibitors can selectively interfere with different stages of simian virus 40 DNA replication.

Authors:  R M Snapka
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

6.  Effects of VM26 (teniposide), a specific inhibitor of type II DNA topoisomerase, on SV40 DNA replication in vivo.

Authors:  A Richter; U Strausfeld; R Knippers
Journal:  Nucleic Acids Res       Date:  1987-04-24       Impact factor: 16.971

7.  Roles of DNA topoisomerases in simian virus 40 DNA replication in vitro.

Authors:  L Yang; M S Wold; J J Li; T J Kelly; L F Liu
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

8.  Camptothecin, a specific inhibitor of type I DNA topoisomerase, induces DNA breakage at replication forks.

Authors:  K Avemann; R Knippers; T Koller; J M Sogo
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

9.  Need for DNA topoisomerase activity as a swivel for DNA replication for transcription of ribosomal RNA.

Authors:  S J Brill; S DiNardo; K Voelkel-Meiman; R Sternglanz
Journal:  Nature       Date:  1987 Mar 26-Apr 1       Impact factor: 49.962

10.  Inhibition of in vitro nuclear transport by a lectin that binds to nuclear pores.

Authors:  D R Finlay; D D Newmeyer; T M Price; D J Forbes
Journal:  J Cell Biol       Date:  1987-02       Impact factor: 10.539

View more
  45 in total

Review 1.  A topological view of the replicon.

Authors:  Jorge B Schvartzman; Andrzej Stasiak
Journal:  EMBO Rep       Date:  2004-03       Impact factor: 8.807

2.  Fork rotation and DNA precatenation are restricted during DNA replication to prevent chromosomal instability.

Authors:  Stephanie A Schalbetter; Sahar Mansoubi; Anna L Chambers; Jessica A Downs; Jonathan Baxter
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-03       Impact factor: 11.205

3.  Topoisomerase II-DNA complexes trapped by ICRF-193 perturb chromatin structure.

Authors:  Thomas Germe; Olivier Hyrien
Journal:  EMBO Rep       Date:  2005-08       Impact factor: 8.807

4.  Topological locking restrains replication fork reversal.

Authors:  Marta Fierro-Fernández; Pablo Hernández; Dora B Krimer; Andrzej Stasiak; Jorge B Schvartzman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-22       Impact factor: 11.205

Review 5.  DNA topoisomerase II and its growing repertoire of biological functions.

Authors:  John L Nitiss
Journal:  Nat Rev Cancer       Date:  2009-04-20       Impact factor: 60.716

6.  Cohesion by topology: sister chromatids interlocked by DNA.

Authors:  Rodrigo Bermejo; Dana Branzei; Marco Foiani
Journal:  Genes Dev       Date:  2008-09-01       Impact factor: 11.361

7.  Direct Evidence for the Formation of Precatenanes during DNA Replication.

Authors:  Jorge Cebrián; Alicia Castán; Víctor Martínez; Maridian J Kadomatsu-Hermosa; Cristina Parra; María José Fernández-Nestosa; Christian Schaerer; Pablo Hernández; Dora B Krimer; Jorge B Schvartzman
Journal:  J Biol Chem       Date:  2015-03-31       Impact factor: 5.157

Review 8.  The structure of the nucleus in normal and neoplastic prostate cells: untangling the role of type 2 DNA topoisomerases.

Authors:  William G Nelson; Michael C Haffner; Srinivasan Yegnasubramanian
Journal:  Am J Clin Exp Urol       Date:  2018-04-01

9.  Importance of disentanglement and entanglement during DNA replication and segregation: Comment on: "Disentangling DNA molecules" by Alexander Vologodskii.

Authors:  David Bates; B Montgomery Pettitt; Gregory R Buck; Lynn Zechiedrich
Journal:  Phys Life Rev       Date:  2016-09-13       Impact factor: 11.025

10.  Interplay of DNA supercoiling and catenation during the segregation of sister duplexes.

Authors:  María Luisa Martínez-Robles; Guillaume Witz; Pablo Hernández; Jorge B Schvartzman; Andrzej Stasiak; Dora B Krimer
Journal:  Nucleic Acids Res       Date:  2009-06-24       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.